|
2025
|
G/S
|
Pharmaceutical preparations for the treatment or prevention of heart failure. |
|
|
G/S
|
Orodispersible film to treat erectile dysfunction; Pharmaceutical preparations and substances; Ve... |
|
2024
|
G/S
|
Orodispersible film to treat erectile dysfunction. |
|
|
G/S
|
Orodispersible film to treat erectile dysfunction; pharmaceuticals; Pharmaceutical preparations a... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations to treat eye conditions; food supplement... |
|
|
G/S
|
Dietary supplement to treat eye conditions; Pharmaceutical preparations to treat eye conditions. |
|
|
G/S
|
pharmaceutical and veterinary preparations and substances in tablet form. |
|
2023
|
G/S
|
Patient support services, namely, providing information to patients relating to diagnostic, proph... |
|
|
G/S
|
Medical information services, namely, providing information relating to sexual dysfunction and th... |
|
2022
|
G/S
|
Providing information relating to causes, symptoms and treatments of erectile dysfunction. |
|
|
G/S
|
Education; educational services; providing of training; arranging and conducting of seminars, con... |
|
|
G/S
|
Pharmaceutical preparations.. |
|
2021
|
G/S
|
Pharmaceutical preparations and substances for the treatment of male erectile dysfunction. |
|
|
G/S
|
Medical information services, namely, providing information
relating to sexual dysfunction and t... |
|
|
Invention
|
Oral solid meloxicam formulations for the treatment of acute pain.
Oral solid pharmaceutical com... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of tuberculosis. |
|
2019
|
G/S
|
Pharmaceutical ophthalmic preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory
ailments. |
|
2018
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory ailments. |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
G/S
|
Pharmaceutical preparations for treating sexual dysfunctions; dietetic substances consisting of v... |
|
2017
|
Invention
|
Solid pharmaceutical compositions containing pregabalin. A solid pharmaceutical composition conta... |
|
|
G/S
|
Pharmaceutical preparations. |
|
2016
|
Invention
|
Forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phen... |
|
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
G/S
|
Wearable activity trackers, namely, multifunctional wearable electronic devices for displaying, m... |
|
2015
|
G/S
|
Multifunctional wearable electronic devices for displaying, measuring, monitoring, and transmitti... |
|
|
Invention
|
Forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino... |
|
|
Invention
|
Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl... |
|
|
Invention
|
Process for annealing amorphous atorvastatin. Processes for annealing amorphous atorvastatin is d... |
|
2014
|
Invention
|
Forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)... |
|
|
Invention
|
Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. |
|
|
G/S
|
Providing instruction concerning the use and operation of epinephrine auto-injectors; providing m... |
|
|
Invention
|
Process for forming amorphous atorvastatin. A process for forming amorphous atorvastatin comprisi... |
|
|
G/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
2013
|
Invention
|
Process for preparing chiral compounds. The present invention is directed to a 2-deoxyribose-5-ph... |
|
|
Invention
|
Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[p... |
|
2011
|
G/S
|
Computer software for medical diagnosis. Printed matter for medical diagnosis. Scientific and tec... |
|
|
Invention
|
Preparation of pregabalin and related compounds. Materials and methods for preparing (S)-(+)-3-am... |
|
|
Invention
|
Forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)c... |
|
2010
|
Invention
|
Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[... |
|
|
G/S
|
Pharmaceutical preparations; sanitary preparations for medical purposes; aforesaid goods includin... |
|
|
G/S
|
Pharmaceutical and veterinary preparations and substances; sanitary preparations for medical purp... |
|
|
G/S
|
medical services; medical information services. |
|
|
G/S
|
Medical education services. |
|
|
G/S
|
Educational services for medical professionals in the field of pain and anxiety. |
|
2009
|
G/S
|
Pharmaceutical preparations, veterinary preparations;
sanitary preparations for medical purposes. |
|
|
G/S
|
Magnetic data carriers, recording discs; data processing equipment and computers; computer hardwa... |
|
2008
|
G/S
|
Printed materials, namely brochures on the topic of overactive bladder. Medical information servi... |
|
|
Invention
|
Preparation of pregabalin and related compounds. Materials and Methods for preparing (S)-(+)-3-am... |
|
|
Invention
|
Salt forms of [r—(r*,r*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl... |
|
2004
|
Invention
|
Prodrugs of amino acids with affinity for the α2δ-protein. This invention relates to prodrugs of ... |
|
2003
|
Invention
|
Liquid pharmaceutical compositions. A liquid pharmaceutical composition of a GABA analog comprisi... |
